InMode (INMD) Dividends Paid - Common Growth (3y) (2021 - 2026)
InMode (INMD) Dividends Paid - Common Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 7.38% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 5.75% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 0.11% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | -16.01% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -599.76% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 9.77% |
| 10 | InMode | 911.60 Mn | 496.43 Mn | 71.52 Mn | 35.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.87% |
| Sep 30, 2025 | 48.52% |
| Jun 30, 2025 | 34.74% |
| Mar 31, 2025 | 48.39% |
| Sep 30, 2024 | 33.73% |
| Jun 30, 2024 | 14.20% |
| Mar 31, 2024 | 23.05% |
| Dec 31, 2023 | 27.95% |
| Sep 30, 2023 | 24.78% |
| Jun 30, 2023 | 35.14% |
| Mar 31, 2023 | 27.23% |
| Dec 31, 2022 | 29.68% |
| Sep 30, 2022 | 16.52% |
| Jun 30, 2022 | 45.20% |
| Mar 31, 2022 | 33.08% |
| Dec 31, 2021 | 40.21% |
| Sep 30, 2021 | 49.51% |
| Jun 30, 2021 | 23.24% |